# Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.

> **NCT04874285** · NA · COMPLETED · sponsor: **Lo.Li.Pharma s.r.l** · enrollment: 63 (actual)

## Conditions studied

- Pregnancy, High Risk

## Interventions

- **DIETARY_SUPPLEMENT:** HA

## Key facts

- **NCT ID:** NCT04874285
- **Lead sponsor:** Lo.Li.Pharma s.r.l
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-03
- **Primary completion:** 2022-05-30
- **Final completion:** 2023-05-11
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2023-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04874285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04874285, "Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT04874285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
